A

pair of religious organizations that own stock in Vertex Pharmaceuticals is pressuring the company to disclose more information about its lobbying efforts, the latest bid by such groups to force the pharmaceutical industry to alter its business practices.

In a shareholder proposal, the organizations want the drug maker to report lobbying procedures and payments; membership in any organization that writes or endorses legislation, such as industry trade groups; and management policies for overseeing lobbying (see page 37).

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy